The Council for Scientific and Industrial Research (CSIR) launched India’s first Ayurvedic anti-diabetic drug in Goa on 23 May 2016. CSIR’s Ayurvedic anti-diabetic drug is ‘BGR-34’ with DPP4. Dr A K S Rawat, senior principal scientist at CSIR-NBRI said, ”Six crore of the adult Indian population has been found to be diabetic and there is no effective solution for diabetes as yet. We are sure that eminent medical professionals will recommend it to their patients sufferingfrom Type-II diabetes mellitus for quicker and consistent response.”
CSIR’s premier research institutions have developed and established the efficiency of BGR-34, while the modern diabetes drugs are known for side-effects and toxicity, BGR-34 is Ayurvedic drug and it works by controlling blood sugar and limiting the harmful effects of other drugs.
BGR-34 is a unique product that manages the lives of humans suffering from diabetes. One of the critical ingredients inhibits DPP-4 and enhances insulin secretion. The product passed several battery of tests and showed hypoglycemic activity in experimental subjects.
Click NEXT to See Product’s Description and Instructions…
This post has been seen 462 times.